Yeqing Zhu resigned as chairman and chief executive officer of New Horizon Health (HKG:6606) on Monday due to health reasons, a Tuesday bourse filing said.
Since the firm believes Zhu's management style differs from that of the other board members, it will convene an extraordinary general meeting to remove him from the post of executive director.
The developer of cancer screening tests named Naxin Yao, a non-executive director, as its new chairman.
Trading in the company's shares, which has been suspended since March 28, remains suspended.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。